BELFAST, Northern Ireland & NEWTOWN, Pa. - Wednesday, August 27th 2014 [ME NewsWire]
(BUSINESS WIRE)-- HeartSine® Technologies is pleased to announce the arrival of the samaritan® PAD 360P, a fully automatic AED (Automatic External Defibrillator) based on the company’s popular samaritan PAD 350P.
The HeartSine samaritan PAD 360P (SAM 360P) analyses the heart rhythm and delivers an electrical shock to a victim of Sudden Cardiac Arrest in order to restore the heart to normal rhythm. This user-friendly AED provides easy to follow visual and audio prompts, including CPR coaching which verbally guides the rescuer through the CPR process. Shock delivery, if required, is fully automatic which means there is no shock button to press.
The SAM 360P utilizes clinically advanced samaritan PAD technology, including proprietary electrode technology, advanced and stable firmware, and proprietary SCOPE™ (Self-Compensating Output Pulse Envelope) biphasic technology (an escalating and low-energy waveform that automatically adjusts for patient impedance differences) to assess rhythm and maximize effective shock delivery if necessary.
“We work closely with our customers to ensure that our products include the features they want most,” says Declan O’Mahoney, HeartSine CEO. “Because the auto-shock feature is required in some markets, we expanded our product offering to include the SAM 360P, which nicely complements our existing product line.”
With a rating of IP56, the samaritan PADs are the most robust AEDs available on the market, providing the highest level of moisture and dust ingress protection in the industry. This makes the HeartSine AEDs equally ideal for use in the corporate office or in the field where exposure to the elements is a challenge.
All HeartSine samaritan PAD models use the company’s innovative Pad-Pak™ cartridge that houses both the battery and electrodes for the device. One expiration date eliminates the need and reduces the costs to track and inventory two separate items, giving the samaritan PAD one of the lowest costs of ownership in the industry. And the Pad-Pak features a rapid replacement mechanism that enables both the pads and the battery, which is also available with EASA's latest ETSO-C142a certification, to be replaced within seconds.
The SAM 360P will complement the SAM 350P by providing users with a choice of either a fully-automatic device or a semi-automatic device.
Along with the SAM 360P, HeartSine will offer a new samaritan PAD Trainer TRN-360 that simplifies CPR and AED training. The new samaritan PAD Trainer guides users through simulated analysis, energy delivery and prompted Cardio Pulmonary Resuscitation (CPR) intervals with the look and feel of a live samaritan PAD 360P without the actual charge and discharge of an electrical shock.
The samaritan PAD 360P is immediately available in several countries in Europe, Asia, Africa and Latin America, and will roll out to additional countries as local regulatory approvals are received. The cost of the device will be comparable to that of the SAM 350P.
Sudden Cardiac Arrest (SCA) is a condition in which the heart suddenly and unexpectedly stops beating, causing blood to stop flowing to the brain and other vital organs. SCA usually causes death if it's not treated within minutes. CPR alone will not restart the heart, so the American Heart Association recommends CPR combined with early defibrillation (within three to five minutes) for the best outcome.
SCA claims more than seven million lives annually. It occurs abruptly and without warning, with 84 percent of SCA events occurring outside of the healthcare setting.
About HeartSine Technologies
HeartSine Technologies, a world leader in personal and public access defibrillators, advances the deployment of life-saving defibrillation therapy for the treatment of Sudden Cardiac Arrest in non-traditional areas of care.
Designed for use in public areas, the company’s entire line of Automatic External Defibrillator (AED) products leverages its proprietary, clinically advanced SCOPE technology to optimize the administration of life-saving treatment.
The company’s flagship product line, the HeartSine samaritan® PAD (Public Access Defibrillator), is IP56 rated for durability and exceptional reliability to meet the unique environmental demands of public use. Its industry-leading warranty and innovative battery/electrode Pad-Pak combine to give the samaritan PAD the lowest total cost of ownership. HeartSine is active in over 70 countries worldwide in a wide range of environments, including commercial aircraft, military and shipping facilities, manufacturing plants, offices, schools and sports clubs.
HeartSine is based in Belfast, Northern Ireland and Newtown, Pennsylvania. To learn how a HeartSine AED can save lives, please visit www.heartsine.com/ or follow HeartSine at Facebook, and Twitter.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50931378&lang=en
Director of Global Marketing